The funding will be used to accelerate innovation for KenSci’s machine learning platform and expand operations to support the company’s rapidly growing customer base. Said platform is engineered to predict clinical risk, financial risk and operational risk, enabling health systems to transition to value-based care. It is built collaboratively with practicing physicians, data scientists, machine learning developers and computing and biomedical researchers.